@article{mbs:/content/journal/jgv/10.1099/vir.0.81628-0, author = "Ford, Patrick W. and Bryan, Benjaman A. and Dyson, Ossie F. and Weidner, Douglas A. and Chintalgattu, Vishnu and Akula, Shaw M.", title = "Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency", journal= "Journal of General Virology", year = "2006", volume = "87", number = "5", pages = "1139-1144", doi = "https://doi.org/10.1099/vir.0.81628-0", url = "https://www.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.81628-0", publisher = "Microbiology Society", issn = "1465-2099", type = "Journal Article", abstract = "Kaposi's sarcoma-associated herpesvirus (KSHV) causes Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease. KSHV infection of cells produces both latent and lytic cycles of infection. In vivo, the virus is found predominantly in the latent state. In vitro, a lytic infection can be induced in KSHV-infected cells by treating with phorbol ester (TPA). However, the exact signalling events that lead to the reactivation of KSHV lytic infection are still elusive. Here, a role is demonstrated for B-Raf/MEK/ERK signalling in TPA-induced reactivation of KSHV latent infection. Inhibiting MEK/ERK signalling by using MEK-specific inhibitors decreased expression of the TPA-induced KSHV lytic-cycle gene ORF8. Transfection of BCBL-1 cells with B-Raf small interfering RNA inhibited TPA-induced KSHV lytic infection significantly. Additionally, overexpression of MEK1 induced a lytic cycle of KSHV infection in BCBL-1 cells. The significance of these findings in understanding the biology of KSHV-associated pathogenesis is discussed.", }